Cognoptix: Simple Eye-Scan Test a Powerful Tool for Diagnosing Alzheimer’s Disease

Cognoptix and its technology have the ability to overhaul commonly accepted Alzheimer’s Disease diagnostic practices, providing a tool to diagnose the disease at an early stage, thereby increasing the efficacy of current therapies.

Read more »

Cognoptix: Eye Scanning Test for Early Detection of Alzheimer’s Disease Represents Significant Market Opportunity

Cognoptix, presenting at the 6th Annaul OneMedForum, January 7-9 in San Francisco, is a privately held medical device company creating and developing a simple, innovative non-invasive eye scanning test for the early detection and diagnosis of Alzheimer’s Disease.

Read more »